Charles Stacey

Dr. Stacey has over 20 years of experience in healthcare working as a provider, entrepreneur and investor. He is President and CEO of Cerecin, a biotechnology company focused on neurology drug development. Prior to Cerecin, Dr. Stacey worked in life science venture capital predominantly with Inventages, a global healthcare venture capital group with $1.5 billion AUM, where he focused on brain health. Before that, Dr. Stacey co-founded a medical device company to develop a product that he invented in his clinical practice. Earlier in his career, Dr. Stacey worked as an orthopaedics and trauma surgeon in London. Dr. Stacey is a member of Board of Governors for the Accreditation Council for Medical Affairs. He also acts as an investor and advisor to a number of life science companies. He received his medical degree from King's College London and completed an MBA at the London Business School and the Wharton School.